^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
New
Title:

T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report

Excerpt:
A 65-year-old man was diagnosed with T-cell lymphoma with abundant CD20 expression…Upon admission to our department, he was administered a rituximab + gemcitabine + oxiplatin + L-asparaginase (R-pGEMOX) regimen and achieved partial remission.
Secondary therapy:
P-GEMOX
DOI:
10.1097/MD.0000000000010199.